Monopar Therapeutics Rings the Opening Bell

ABOUT THIS EVENT

Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve quality of life for cancer patients, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Chandler D. Robinson, Co-Founder & CEO, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore